Secondary analysis of TOLSURF (511 ventilated infants born <28 weeks): patent ductus arteriosus status did not modify the effect of late surfactant on survival without bronchopulmonary dysplasia at 36 or 40 weeks' postmenstrual age.
Secondary analysisn = 511
Peebles et al. Effect modification of late surfactant treatment by patent ductus arteriosus status in ventilated preterm infants: a secondary analysis of a randomized clinical trial